Oct 24, 2025 16:20
ALKS - Alkermes Inc. plc
| Day | 1m | 10m | 60m | PreMarket | Market | AfterHours | Gap |
|---|---|---|---|---|---|---|---|
| 28.6 0.02 (0.07%) | -0.01 (-0.03%) | 0.0 (0.0%) | -0.09 (-0.31%) | -0.51 (-1.78%) | 0.52 (1.85%) | --- | -0.51 (-1.78%) |
Alkermes PLC is a fully integrated biotechnology company that applies its proprietary technologies to research, develop, and commercialize pharmaceutical products designed for unmet medical needs in therapeutic areas. The company utilizes several to develop and commercialize products and, in so doing, access technological, financial, marketing, manufacturing, and other resources. Alkermes either purchases active drug products from third parties or receives them from its third-party licensees to formulate products using its technologies. It operates in U.S., which derives maximum revenue, Ireland and Rest of the world.
Earnings & Ratios
- Basic EPS:
- 0.53
- Diluted EPS:
- 0.52
- Basic P/E:
- 54.0
- Diluted P/E:
- 55.0385
- RSI(14) 1m:
- 50.0
- VWAP:
- 28.62
- RVol:
Events
| Period | Kind | Movement | Occurred At |
|---|
Related News
Oct 22, 2025 21:30
Oct 22, 2025 19:18
Jul 15, 2024 21:00
Jun 24, 2024 12:07
May 31, 2024 15:31
May 27, 2024 10:20
May 23, 2024 16:00
May 21, 2024 12:48
May 02, 2024 18:00